BioSpace News Archive

Dental amalgam is a controversial filling material that is 50% mercury.

Caribou Biosciences, Inc., a leading CRISPR genome editing company, announced the publication of a new study demonstrating human genome engineering with Type I CRISPR-Cas systems.

On a beautiful Orange County morning, Avanir Pharmaceuticals, Inc. joined the nonprofit Alzheimer’s Orange County to raise awareness and funds to fight Alzheimer’s and dementia

Dr. Lotto has published and presented research on vascular surgery and other topics in medical journals and at regional and national conferences.

Featuring pioneers in molecular biology, inaugural lecture to take place on November 20th, 2019.

ConvenientMD is an all-inclusive solution for treating a broad range of injuries and illnesses, led by the area’s leading physicians and providers.

Financial results for the quarterly period ended September 30, 2019 on Wednesday, December 4, 2019, after the close of the market.

Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) today announced the appointment of Kathleen D. Scott to the Conatus Board of Directors as an additional independent member.

Lipocine Inc. (NASDAQ:LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced the closing of a public offering of (i) 10,450,000 Class A Units, each consisting of shares of its common stock and common warrants to purchase its common stock and (ii) 1,550,000 Class B Units consisting of pre-funded warrants and warrants to purchase its common stock

Varian announced the South Florida Proton Therapy Institute, a Proton International facility, on the campus of Delray Medical Center, has treated its first patient utilizing the Varian ProBeam® Compact single-room proton therapy system.